Nifty Pharma Prediction for Monday, 17 August 2026: Defensive Premium Partially Unwinds as TCS -0.80% (Day 2 IT stalled) Reduces IT-Fear — Sector May Underperform Friday

The Nifty Pharma prediction for Monday for Monday 17 August 2026 is shaped by Thursday's twin macro developments: MCX Crude Oil crashing -1.88% to Rs 7,803 ; its sharpest single-day fall this week and lowest level since before Tuesday's Iran-deal-stall surge ; and TCS bouncing +1.08% to Rs 2,356, confirming IT sector recovery after Wednesday's -3.93% crash. Nifty 50 closed at 24,354.85 (-0.17%) in its fourth consecutive opening-high distribution session, while the Sensex defied the trend at 77,931.10 (-0.19%). Bank Nifty slipped -0.43% to 57,459.10 after ICICI Bank fell -1.74%, blocking the Day 6 banking rotation for a second consecutive day. The Nifty Pharma index is the primary reference for Friday's session.

Ankit Jaiswal, Senior Research Analyst at Univest, and Kunal Singla, Associate Director at Univest, frame the Nifty Pharma prediction for Monday around crude oil's -1.88% Thursday fall as the dominant macro shift heading into Friday. At Rs 7,803 ; down from Rs 8,024 on Tuesday in just two sessions ; crude's 3% retreat provides substantial input cost relief to auto, FMCG, cement and chemicals sectors. Simultaneously, IT sector recovery (TCS -0.80% (Day 2 IT stalled), HCL Tech +0.34%) provides a second positive catalyst. Together, these two themes make the Nifty Pharma prediction for Monday the most opportunity-rich of the week, even as banking consolidates after Thursday's ICICI Bank +0.40% (finally recovered Friday).

Click Here – Get Free Investment Predictions

Thursday's Market Recap for the Nifty Pharma prediction for Monday

Indicator	Fri 17 Aug Close (Groww)	Change	Signal for Friday
Nifty 50	24,354.85	-0.16%	4th Open=High distribution; L:24,311; floor at 24,265 intact
Sensex	77,931.10	+0.15%	Only index green; TCS -0.80% (Day 2 IT stalled) drove this; L:77,399
Bank Nifty	57,459.10	-0.43%	Open=High session; ICICI +0.40% (finally recovered) primary drag; L:57,548
MCX Crude Oil	Rs 7,803/bbl	-1.88%	Largest single-day fall this week; below Rs 7,800; Iran deal signals
MCX Gold	Rs 1,52,220/10g	-0.37%	Mild pullback from Wed high; L:1,52,250; support intact
MCX Silver	Rs 2,36,198/kg	-0.80%	Correcting from Wed bounce; L:2,34,700
MCX Copper	Rs 1,373.55/kg	-0.29%	Mild dip; L:1,357.55; industrial demand intact
MCX Zinc	Rs 398.30/kg	-0.51%	L:390.45; supply deficit still alive
MCX Nat Gas	Rs 263.70/MMBTU	-0.60%	L:265.80; consolidating above Rs 265
TCS	Rs 2,356	+1.08%	IT Day 1 recovery; NASDAQ bounce confirmed; H:2,375
ICICI Bank	Rs 1,412.40	-1.74%	Day 6 rotation failed; Rs 1,435 held; new support Rs 1,395-1,410
SBI	Rs 1,083	+0.09%	PSU banking stable; H:1,086.80; floor at Rs 1,073
Reliance	Rs 1,317	-0.90%	Worst session this week; L:1,307.20; crude fall helps O2C Fri

Nifty Pharma prediction for Monday: Key Factors for Friday

• TCS recovering +1.08% Thursday is Friday's primary challenge. When TCS bounces from Wednesday's -3.93% crash, portfolio managers who bought pharma and healthcare as IT hedges partially exit those defensive positions. Ankit Jaiswal estimates 30-40% of the defensive pharma premium from Wednesday was unwound Thursday ; creating a mild Friday headwind for Friday's session if IT sector recovery continues.
• The residual defensive premium for Friday's session comes from Nifty's fourth consecutive opening-high distribution day and VIX at an estimated 13.80-14.20. Even with TCS recovering, four days of distribution and approaching-14 VIX mean some institutional portfolios maintain pharma as a portfolio hedge for Friday's session Friday session.
• Crude oil crashing -1.88% to Rs 7,803 Thursday has a mild positive effect on hospital operators (lower ambulance fuel and equipment energy costs) for Friday's session. Pharmaceutical API manufacturers remain crude-insensitive. Net effect: Apollo Hospitals gets a marginal crude benefit while pharma manufacturers are broadly unaffected by Thursday's crude direction.
• If TCS continues higher Friday (Day 2 IT recovery) and ICICI Bank also recovers (Day 6 rotation re-attempt), the market would be broadly risk-on. In that scenario, Kunal Singla estimates the Nifty Pharma prediction for Monday underperforms Nifty by 0.5-0.8 percentage points as full defensive rotation exits pharma and re-enters growth sectors (IT, banks, auto) simultaneously.

Technical Levels for the Nifty Pharma prediction for Monday

Level	Zone	Why It Matters
Primary Support	26,580-26,660	Confirmed buyer zone from Thursday's session; DII accumulation visible
Secondary Support	26,320-26,420	Deeper correction floor ; only matters if primary breaks on Friday
Immediate Resistance	26,900-27,000	First recovery target for Friday; partial booking zone
Extended Resistance	27,200-27,350	Breakout target if Friday session builds on Thursday momentum

Stocks Flagged for the Nifty Pharma prediction for Monday

Stock	Thu Close	Entry Zone	Target	Stop Loss	Analyst	Why Now
Sun Pharma	Rs 1,942 est.	Hold above Rs 1,920; new entry only if VIX > 14	Rs 1,992	Rs 1,895	Ankit Jaiswal	Primary Nifty Pharma prediction for Monday defensive anchor. Above Rs 1,942 = defensive premium partially sustaining Friday.
Cipla	Rs 1,462 est.	Rs 1,450-1,465 (hold only)	Rs 1,498	Rs 1,422	Kunal Singla	Diversified India-US portfolio breadth. Nifty Pharma prediction for Monday hold if VIX stays above 13.80.
Apollo Hospitals	Rs 8,720 est.	Rs 8,680-8,730	Rs 8,970	Rs 8,500	Ankit Jaiswal	Hospital operator crude cost relief from Rs 7,803. Selective Nifty Pharma prediction for Monday add if broader pharma selling creates an entry.

Screen All Stocks for Friday's session on Univest Screener

Strategy for the Nifty Pharma prediction for Monday Session

1. Hold existing Nifty Pharma prediction for Monday positions rather than adding new defensive pharma exposure Friday. The premium has partially unwound.
2. Sun Pharma above Rs 1,942 Friday = residual Nifty Pharma prediction for Monday defensive premium intact; below Rs 1,920 = full exit from pharma defensive positions.
3. If Nifty gaps above 24,450 (distribution ceiling) Friday, that is the signal to fully exit defensive Nifty Pharma prediction for Monday positions and rotate into IT or auto.
4. Kunal Singla: Apollo Hospitals is Friday's component that benefits from crude -1.88% ; selectively add Apollo if broader pharma sector sees selling on IT recovery.

Key Risks to the Nifty Pharma prediction for Monday

• TCS Day 2 recovery continuing Friday, triggering full defensive rotation exit from pharma on Friday ; sector underperforms significantly.
• Iran deal confirming overnight, removing all crude-related risk premia and the last defensive rotation argument for Friday's session.
• US FDA warning letters on Indian pharma manufacturing adding sector-specific headwinds to the Friday's pharma outlook.

Conclusion

The Friday's pharma outlook for Monday 17 August 2026 has crude oil's -1.88% Thursday fall to Rs 7,803 as its most important macro input. Ankit Jaiswal of Univest identifies primary support at 26,580-26,660 and immediate resistance at 26,900-27,000 for Friday's session, with the crude relief trade (auto, FMCG, cement) and IT recovery (TCS, HCL Tech) as Friday's two highest-conviction positive themes.

Kunal Singla of Univest adds that ICICI Bank's Thursday -1.74% creates a buy-on-dip entry at Rs 1,395-1,412 for banking sector exposure ; lower than Wednesday's entry, same Rs 1,432-1,442 target. Check GIFT Nifty above 24,420 and NASDAQ above 22,000 at 9 AM Friday as the two pre-market signals that confirm Friday's positive bias for Friday's session.

FAQs on Nifty Pharma Prediction For Monday, 17 August 2026

What is the Nifty Pharma prediction for Monday, 17 August 2026?

Ans. Flat to slightly negative. TCS -0.80% (Day 2 IT stalled) recovery unwound 30-40% of defensive pharma premium from Wednesday. Nifty 4th distribution day and VIX 13.80-14.20 keep residual premium. Support 26,580-26,660, resistance 26,900-27,000.

Which analysts prepared the Nifty Pharma prediction for Monday?

Ans. Ankit Jaiswal, Senior Research Analyst, and Kunal Singla, Associate Director at Univest.

How does TCS's +1.08% recovery affect the Nifty Pharma prediction for Monday?

Ans. TCS recovering +1.08% reduces the IT-sector-fear argument that drove defensive pharma rotation since Wednesday. Portfolio managers who bought pharma as an IT hedge exit 30-40% of that position Thursday ; creating a mild Friday's pharma outlook headwind for Friday if TCS continues its Day 2 recovery.

What is support and resistance for the Nifty Pharma prediction for Monday?

Ans. Support 26,580-26,660 and 26,320-26,420. Resistance 26,900-27,000 and 27,200-27,350.

Which stocks are watched in the Nifty Pharma prediction for Monday?

Ans. Sun Pharma (defensive anchor Rs 1,942 threshold), Cipla (sector breadth hold) and Apollo Hospitals (crude cost relief selective add) on Friday.